ANTICOAGULANT TREATMENT IN ADDITION TO IMMUNOSUPPRESSIVES DECREASES THE RELAPSE RATE IN PULMONARY ARTERIAL INVOLVEMENT OF BEHÇET’S DISEASE

Background: Vascular inflammation in Behcet’s Disease (BD) is one of the most important causes of mortality due to pulmonary artery involvement (PAI) or Budd-Chiari syndrome. Objectives: In this study, we aimed to retrospectively evaluate the clinical features, course and factors affecting the recurrence risk of BD-associated PAI. Methods: BD patients followed up between 1990-2022 were included. All data were acquired from the patient charts. Involvements were classified according to the vascular structures in which thrombotic or aneurysmal formation was detected. Factors affecting the risk of relapses were determined using multivariate Cox regression analysis. Results: Among 1350 BD patients, 110 (8.1%) had PAI. The mean age (SD) of patients with PAI was 42.4 (11.6) years, and the male/female ratio was 2.2 (76/34). Thirty-two (29.1%) of 110 patients were asymptomatic. Symptomatic patients were significantly older (p=0.031), and female gender (p=0.001) and recurrence (p=0.019) rates were higher than asymptomatic patients. Thrombotic involvement was seen in 104 (94.5%) and aneurysms in 9 (6.6%) patients. (Figure 1) Relapses were observed at least once in 31 (28.2%) patients. In multivariate analysis, the Cox regression model was significant (p=0.015) and not starting anticoagulants (HR 5.11, 95% CI 1.21-21.6), p=0.026), independently increased the relapse risk. (Table 1) Conclusion: PAT is the main presentation type of PAI in BD while aneurysmatic formation is rare. In one-third of patients with PAI, relapses develop during follow-up despite immunosuppressive treatment. When added to immunosuppressive treatment, anticoagulant therapy significantly decreases the relapse rate in BD patients with PAI. REFERENCES: NIL. Figure 1. The distribution of patients is classified according to symptom status, size of involved vessels and acute phase reactant levels at the time of diagnosis of PAI. Acknowledgements: NIL. Disclosure of Interests: None declared. DOI: 10.1136/annrheumdis-2024-eular.4605 Keywords: Cardiovascular diseases, Observational studies/registry Citation: , volume 83, supplement 1, year 2024, page 435Session: Clinical Poster Tours: Miscellaneous in Vasculitis (Poster Tours)

Cardiovascular diseases, Observational studies/registry